Status : Published | Published On : Jan, 2023 | Report Code : VRHC1228 | Industry : Healthcare | Available Format :
![]() |
Page : 191 |
Industry Overview
The European isolation beds market is growing at a CAGR of 6.0% in terms of volume during the forecast period (2023–2030). The key factor driving the industry is the sudden outbreak of COVID-19. The drastic changes occurring due to COVID-19 are impacting every hospital in the region as a result of which demand for isolation beds is increasing rapidly. The government has requested all the manufacturers of isolation beds in the region to increase the production of these beds. According to the European Centre for Disease Prevention and Control, as of 26th April 2020, the number of confirmed coronavirus cases was around 1,214,584, and confirmed deaths due to COVID-19 were around 119,306 in Europe. The Europe isolation beds market refers to the market for specialized beds designed to isolate patients who have contagious diseases or infections. These beds are equipped with features that help prevent the spread of pathogens and protect healthcare workers and other patients from potential contamination.
To cope up with these outbreaks in hospitals, and other health centers, these centers are required to follow preventive measures of isolating infected patients. Viral infections can spread significantly to other healthcare workers, visitors, and doctors. So, it is mandatory to have separate isolation wards with efficient medical facilities and preventive personal equipment for doctors and health workers. For COVID-19 disease, isolation is the primary step, this is why specialized cabins or isolation wards have been created within the hospital settings. This, in turn, growing the demand for isolation beds in the European market.
Market Segmentation
Insight by Type
The manual category dominated the isolation beds market in 2022, on the basis of type in the European isolation beds market. Manual isolation beds are less expensive and require minimum manufacturing costs as compared to other isolation beds. As the number of coronavirus-affected people are significantly growing in Europe, the demand for manual isolation beds is expected to increase over the forecast period.
Insight by Usage
During the forecast period, the medical surgery classification is projected to witness the fastest isolation beds market growth, based on usage. This is because of the increasing occurrence of surgical procedures in the European market.
Insight by End Use
The general & acute care hospitals division, under the end-use segment, would hold the largest share of the isolation beds market in 2019 & 2020. This is attributed to the growing need for intensive care units (ICU) due to the COVID-19 pandemic. The presence of general hospitals as compared to specialized and multi-specialty hospitals is the primary factor behind the growth of the segment.
Study Coverage |
Details |
Market Size Available for the Years in the Study |
2018 – 2030 |
Historical Period |
2018 – 2022 |
Base Year |
2022 |
Forecast Period |
2023 – 2023 |
Market Representation in the Study |
In terms of Revenue in (USD Million), In terms Volume (Units), and CAGR from 2018 to 2022 (Historical), and 2023 to 2030 (Forecast) |
Geographies Covered in the Study |
Germany, U.K., France, Italy, Spain, Russia |
Companies Covered in the Study |
Invacare Corporation, Joerns Healthcare, Arjo Huntleigh (Division of Gentige AB), LINET Group, Joh. Stiegelmeyer GmbH & Co. KG, Stryker Corporation, Hill Rom Inc., Paramount Bed Holdings Co., Ltd., Medline Industries, Gendron, Inc., Span-America Medical Systems, Inc., Savion Industries Ltd., Stiegelmeyer GmbH & Co. Kg, and Malvestio S.P.A. |
15% Free Customization in the Scope of the Report |
If you have any specific requirement, which is not being covered in the scope of the report, our research team can produce a customized report as a part of the customization |
Industry Dynamics
Industry Trends
The market for isolation beds in Europe is expected to continue growing in the coming years due to ongoing efforts to improve infection control measures in healthcare settings. Additionally, advancements in technology and the development of more sophisticated isolation bed systems are likely to drive market growth.
Growth Drivers
The rise in the number of coronavirus cases in Europe is one of the major factors boosting the market growth. The market is predicted to show approximately 100% growth from the year 2019 to 2020. The growing rate of COVID-19 cases has generated a potential market for isolation beds across Europe. Key factors driving the Europe isolation beds market include the increasing prevalence of infectious diseases, the need for infection control measures in healthcare settings, and the rising focus on patient safety. The COVID-19 pandemic has further highlighted the importance of isolation beds in managing contagious diseases.
Significantly increasing confirmed cases of COVID-19 are motivating the intensive care community in the healthcare market to prepare for the situation associated with COVID-19 pandemic. Therefore, coronavirus-affected countries in Europe are continuously focusing on increasing their isolation bed capacity, which in turn, helps in market expansion. According to the current news article, the patients that survive the infection of COVID-19 usually require an average of 15 days in intensive care units. Hence, rising coronavirus cases are expected to increase the European isolation beds market growth over the forecast period (2023–2030).
The demand for isolation beds in Europe has been driven by factors such as the increasing prevalence of infectious diseases, growing concerns about hospital-acquired infections, and the need for effective infection control measures. The COVID-19 pandemic, in particular, has significantly boosted the demand for isolation beds across the region.
Challenges
However, due to the coronavirus preventive lockdown situation in several countries, the manufacturing and supply chains of the isolation beds have been critically affected. The procurement, transportation, and distribution of raw materials to the manufacturing unit and the absence of laborers in both emerging and developed nations have negatively impacted the desired production flow.
Geographic Overview
Geographically, Spain's isolation beds market size in terms of volume is estimated to grow significantly in the European isolation beds market in 2020, owing to the significant rise in the number of coronavirus-positive cases across the country. The coronavirus-affected critically ill patients require specialized ICU admissions to provide advanced care in order to minimize the infection. Therefore, a surge is observed in the demand for isolation beds across the country.
The government authorities in Europe have allotted funds towards COVID-19 in the following manner; Germany is expected to incur USD 808 billion, France USD 50 billion, Spain USD 223 billion, and the U.K. USD 14.8 billion. As a result of huge initiatives undertaken by government authorities to fight COVID-19 is significantly attributing towards the growth of the isolation beds market.
Competitive Insight
The key players operating in the European isolation beds market are Invacare Corporation, Joerns Healthcare, Arjo Huntleigh (Division of Gentige AB), LINET Group, Joh. Stiegelmeyer GmbH & Co. KG, Stryker Corporation, Hill Rom Inc., Paramount Bed Holdings Co., Ltd., Medline Industries, Gendron, Inc., Span-America Medical Systems, Inc., Savion Industries Ltd., Stiegelmeyer GmbH & Co. Kg, and Malvestio S.P.A.
The Europe Isolation Beds Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2023–2030.
Europe Isolation Beds Market by Country
Europe Isolation Beds Market